In the breast cancer cell line MDA-MB-231, the genes ID2 and ID3 have been demonstrated to be under the control of P-TEFb, and reduced P-TEFb recruitment/activity has been suggested to underlie downregulated expression of ID2 and ID3 upon MEPCE depletion37. The gene discussed is ID2; the disease is breast carcinoma.